Document:

qhc-ex105_244.htm

Exhibit 10.5

QUORUM HEALTH CORPORATION
2018 RESTRICTED STOCK PLAN

RESTRICTED STOCK AGREEMENT

 

Pursuant to the terms of the Quorum Health Corporation 2018 Restricted Stock Plan (the "Plan"), and as further set forth herein, you have been granted an Award of Restricted Stock, as follows:

 

Upon and subject to the Additional Terms and Conditions attached hereto and incorporated herein by reference as part of this Award, the Company hereby awards as of the Date of Grant to the Participant the Restricted Stock described below in consideration of the Participant’s services to the Company.

 

	
A.
	
Date of Grant:  The date specified in your electronic Award notification.

 

	
B.
	
Restricted Stock Award:  The Company hereby grants to you this Award of shares of Restricted Stock in the number set out in an electronic notification to you by the Company’s stock plan administrator, as may be appointed from time to time.

 

	
C.
	
Vesting Schedule:  Unless earlier forfeited in accordance with the Plan or this Agreement, the Restricted Stock shall become vested upon the earliest to occur of an involuntary termination by the Company without "Cause", termination by the Participant for "Good Reason", the Participant’s death or "Disability" or a Vesting Date in accordance with the following schedule:

 

    Percentage of Restricted Stock

Vesting Date         which are Vested Shares

 

     100%

 

The shares of Restricted Stock which have become vested pursuant to the Vesting Schedule are herein referred to as the "Vested Shares."  If a tranche of Restricted Stock that becomes vested includes a fraction of a share, such fractional share shall be rounded up or down to the next nearest whole number.

 

Any portion of the Award that has not become Vested Shares in accordance with the Vesting Schedule before or at the time the Participant terminates employment or the Company terminates the Participant’s employment with the Company, other than termination by the Company without Cause or by the Participant for Good Reason or the Participant’s death or Disability, shall be forfeited.

 

	
D.
	
Deemed Execution:  On the date of your electronic acceptance of the terms of the Award and this Agreement, this Agreement shall be deemed to have been executed and delivered by you and the Company.

 

 

1

 

 

ADDITIONAL TERMS AND CONDITIONS OF

QUORUM HEALTH CORPORATION
RESTRICTED STOCK AGREEMENT

 

Capitalized terms shall have the meaning set forth in the Plan, unless expressly set forth to the contrary in this Restricted Stock Agreement.

1.Code Section 83(b) Election.  The Participant acknowledges that the Participant may make an election under Section 83(b) of the Code, provided such election is made within 30 days of the Grant Date and a copy of such election is provided to the Company.

2.Issuance of Restricted Stock.  

(a)The Company shall issue the Restricted Stock as of the Grant Date in one or more of the manners described below, as determined by the Company, in its sole discretion:

(i)by the issuance of share certificate(s) evidencing Restricted Stock to the Secretary of the Company or such other agent of the Company as may be designated by the Company or the Secretary (the "Share Custodian"); or

(ii)by documenting the issuance in uncertificated or book entry form on the Company’s stock records; or

(iii)by the issuance of certificates registered in the name of the Participant which shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award in substantially the following form:

"The transferability of the shares represented by this certificate is subject to the terms and conditions (including forfeiture) of a Restricted Stock Agreement entered into between the registered owner and the Company.  A copy of such agreement is on file in the offices of the Secretary of the Company at 1573 Mallory Lane, Brentwood, Tennessee 37027."

(b)In the event that the Participant forfeits any of the Restricted Stock, the Company shall cancel the issuance on its stock records and, if applicable, the Share Custodian shall promptly deliver the share certificate(s) representing the forfeited shares to the Company.

(c)Participant hereby irrevocably appoints the Share Custodian, and any successor thereto, as the true and lawful attorney-in-fact of Participant with full power and authority to execute any stock transfer power or other instrument necessary to transfer any Restricted Stock to the Company in accordance with this Award, in the name, place, and stead of the Participant.  The term of such appointment shall commence on the Grant Date of this Award and shall continue until the last of the Restricted Stock are delivered to the Participant as Vested Shares or are returned to the Company as forfeited Restricted Stock.

(d)In the event the number of shares of Common Stock is increased or reduced as a result of a subdivision or combination of shares of Common Stock or the payment of a stock dividend or any other increase or decrease in the number of shares of Common Stock or other transaction such as a merger, reorganization or other change in the capital structure of the Company, the Participant agrees that any certificate representing shares of Common Stock or other securities of the Company issued as a result of any of the foregoing shall be delivered to the 

1

 

 

Share Custodian or recorded in book entry form, as applicable, and shall be subject to all of the provisions of this Award as if initially granted hereunder.

3.Rights of a Stockholder.  Upon issuance of the shares of Restricted Stock, the Participant shall have all of the rights of a stockholder with respect to such shares, including the right to vote the shares and to receive all dividends or other distributions paid or made with respect thereto.

4.Compliance With Laws.  The Plan, the granting and vesting of this Award under the Plan, the issuance and delivery of the Restricted Stock, and the payment of money or other consideration allowable under the Plan or this Award are subject to compliance with all applicable federal and state laws, rules and regulations (including, but not limited to, state and federal securities laws and federal margin requirements) and to such approvals by any listing, regulatory or governmental authority as may, in the opinion of counsel for the Committee, the Board or the Company, be necessary or advisable in connection therewith. Any securities delivered under the Plan shall be subject to such restrictions, and the person acquiring such securities shall, if requested by the Company, provide such assurances and representations to the Company as the Committee, the Board or the Company may deem necessary or desirable to assure compliance with all applicable legal requirements. To the extent permitted by applicable law, the Plan and this Award shall be deemed amended to the extent necessary to conform to such laws, rules and regulations. Nothing in the Plan or in this Award shall require the Company to issue any Company Stock with respect to the Award if, in the opinion of counsel for the Company, that issuance could constitute a violation of any applicable laws. As a condition to the grant or exercise of the Award, the Company may require the Participant (or, in the event of the Participant’s death, the Participant’s legal representatives, heirs, legatees or distributees) to provide written representations concerning the Participant’s (or such other person’s) intentions with regard to the retention or disposition of the Restricted Stock and written covenants as to the manner of disposal of such Stock as may be necessary or useful to ensure that the grant, exercise or disposition thereof will not violate the Securities Act, any other law or any rule of any applicable securities exchange or securities association then in effect. The Company shall not be required to register any Company Stock under the Securities Act or register or qualify any Company Stock under any state or other securities laws.

5.Successors.  This Award shall be binding upon and inure to the benefit of the heirs, legal representatives, successors, and permitted assigns of the parties.

6.Entire Agreement.  Subject to the terms and conditions of the Plan, this Award expresses the entire understanding and agreement of the parties.  This Award may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument.

7.Plan Incorporated by Reference. This grant of Restricted Stock is made pursuant to the Plan, and in all respects will be interpreted in accordance with the Plan. The Committee has the authority to interpret and construe this Restricted Stock Agreement pursuant to the terms of the Plan, and its decisions are conclusive as to any questions arising hereunder. The Participant hereby acknowledges receipt from the Company of a copy of the current version of the Plan, which shall be deemed to be incorporated in and form a part hereof. The Participant acknowledges that in the event of any conflict between the terms of this Restricted Stock Agreement and the terms of the Plan, as the same may be amended and in effect from time to time, the terms of the Plan shall prevail.

8.No Employment or Other Rights. This grant of Restricted Stock does not confer upon the Participant any right to be continued in the employment of the Company or any subsidiary or interfere in any way with the right of the Company to terminate the Participant’s employment at any time, for any reason, with or without Cause, or to decrease the Participant’s compensation or benefits. This grant of 

2

 

Restricted Stock is a one-time benefit and does not create any contractual or other right to receive additional Restricted Stock or other benefits in lieu of Restricted Stock in the future.

9.Applicable Law. The validity, construction, interpretation and effect of this Restricted Stock Agreement will be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflicts of laws provisions thereof.

10.Notice. Any notice to the Company provided for in this Restricted Stock Agreement shall be addressed to Quorum Health Corporation at its principal business address in care of the Corporate Secretary of the Company, and any notice to the Participant will be addressed to the Participant at the current address shown on the books and records of the Company. Any notice shall be sent by registered or certified mail, overnight courier service or by electronic delivery.

11.Amendment. This Restricted Stock Agreement may not be amended, modified or waived except by a written instrument signed by the party against whom enforcement of any such modification, amendment or waiver is sought.

12.Severability.  The invalidity or unenforceability of any provision of the Plan or this Restricted Stock Agreement shall not affect the validity or enforceability of any other provision of the Plan or this Restricted Stock Agreement, and each provision of the Plan and this Restricted Stock Agreement shall be severable and enforceable to the extent permitted by law.

3Exhibit

Exhibit 10.1

Amendment #1 to Supply Agreement Radius Health, Inc. – Ypsomed AG
Amendment # 1 to Supply Agreement

This Amendment # 1 to Supply Agreement (“Amendment # 1”) is made by and between

Radius Health, Inc., a Delaware corporation having an address of 950 Winter Street, Waltham, MA 02451 USA
(“Radius”)

and

Ypsomed AG, Brunnmattstrasse 6, 3401 Burgdorf, Switzerland
(“Ypsomed”).

WHEREAS, Radius and Ypsomed have entered into a Supply Agreement, effective as of September 30, 2015 (“Supply Agreement”) regarding the commercial supply of a customized version of Ypsomed’s UnoPenTM injection device for use with Radius’ abaloparatide cartridges;

WHEREAS, Radius, Ypsomed and OneWorldTM DMG, LTD, 30 Technology Dr, Warren, NJ 07059, USA (“OneWorld”) have entered into a Material Transfer Agreement, effective as of 1 November 2016 under which Ypsomed provided Component Sets to Radius and OneWorld for the purpose of evaluating the potential of the development by OneWorld of training device versions of the BA058 Device (technically not capable to deliver drug substances) for patient training purposes only (“Training Device”).

WHEREAS, Radius desires to pursue the development and manufacture by OneWorld of the Training Device and requests a license from Ypsomed for this purpose.

NOW, THEREFORE, in consideration of the premises set out above and of the following mutual promises, covenants and conditions hereinafter set forth, the Parties agree as follows:

		
	1.
	All defined terms used and not otherwise defined in this Amendment # 1 have the meanings ascribed to such terms in the Agreement.

		
	2.
	Section 18.4 of the Agreement shall be renumbered as to read: Section 18.4 (a). The content of the former Section 18.4 shall continue in full force and effect under the newly numbered Section 18.4 (a).

		
	3.
	A new Section 18.4 (b) shall be integrated into the Agreement to read as follows:

“Notwithstanding any other provision in this Agreement to the contrary, Ypsomed grants to Radius a royalty-free and non-exclusive license in respect of the Ypsomed Intellectual Property Rights to the extent required for Radius (i) to have developed and manufactured the Training Device by OneWorld and (ii) to use such Training Device for training purposes in the Territory, and for no other purpose whatsoever. The license shall not include the right to manufacture or have manufactured the Components, Component Sets nor any other version of the UnoPenTM. The license granted under this Section 18.4 (b) shall continue to be effective only as long as the license granted under Section 18.4 (a) of this Agreement remains effective.”
		
	4.
	All other terms and conditions of the Supply Agreement not specifically amended or modified hereby will remain in full force and effect.

		
	5.
	This Amendment # 1 shall be made effective as of the date of the last signature below.

Exhibit 10.1

IN WITNESS WHEREOF, the Parties have caused this Amendment # 1 to be duly executed by their duly authorized representatives in two original counterparts.

	
					
	Radius Health, Inc.
	 
	Ypsomed AG

	Date:
	Feb. 2, 2017
	 
	Date:
	Feb. 7, 2017

	By:
	/s/ Gregory C. Williams, PhD MBA
	 
	By:
	/s/ Ulrike Bauer

	Print Name:
	Gregory C. Williams, PhD MBA
	 
	Print Name:
	Ulrike Bauer

	Title:
	Chief Development Officer
	 
	Title:
	SVP Marketing & Sales Delivery Systems

	By:
	/s/ David C. Hanley, PhD
	 
	By:
	/s/ Frank Schiffmaun

	Print Name:
	David C. Hanley, PhD
	 
	Print Name:
	Frank Schiffmaun

	Title:
	Exec. Dir., Technical Operations
	 
	Title:
	Account Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]